SCR-LIP-000601 · Claim · machine-readable JSON →
Ultrasound is used to measure subcutaneous thickness and stiffness for monitoring lipedema treatment, separately from diagnosis.
General proposition consolidated from 3 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 3 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (3)
- Optimizing Liposuction in Lipedema Patients: A Novel Approach with Perioperative and Intraoperative Ultrasound. — Munoz J, Fons S, Fabbri M. (2026) ✓ verified — consistent · case series · 2026 · reading confidence: high
“Perioperative US was used to measure the thickness of the superficial subcutaneous fat (D1) and the deep fat layer (D2) at a standardized anatomical site.”
In 24 women undergoing liposuction, perioperative ultrasound showed superficial subcutaneous fat (D1) decreasing from 9.9 mm to 6.3 mm.
The article uses ultrasound to measure and monitor fat reduction during liposuction, not to diagnose or classify lipedema; it is on-topic regarding ultrasound in lipedema but does not test diagnostic/classification utility. - Clinical, ultrasound, elastography and bioimpedance changes after radial extracorporeal shock wave therapy in patients with lipedema: A prospective within-patient study. — Novo Rigueiro M, Bravo González M, Prado Moraña T, Pena Dubra A, Villarroel Comesaña S, Navarro Núñez P, Villamayor Blanco B, Novo Veleiro I. (2026) ✓ verified — consistent · case series · 2026 · reading confidence: high
“Ultrasound and elastography were used to evaluate subcutaneous tissue thickness and stiffness at predefined leg and thigh sites”
Ultrasound and elastography measured subcutaneous thickness and stiffness at predefined leg and thigh sites to evaluate changes after radial shock wave therapy.
Ultrasound/elastography were used for tissue measurement and treatment monitoring, not to diagnose or classify lipedema; diagnosis was clinical. The article is on-topic regarding ultrasound imaging in lipedema but does not test its diagnost - Serrapeptase After Liposuction for Lipedema: Limited Evidence for Antifibrotic Efficacy. — Bruno A, Saccoccio V. (2026) ✓ verified — consistent · cohort · 2026 · reading confidence: high
“The primary outcome was tissue stiffness measured by quantitative ultrasound elastography (QUS). Secondary outcomes included B-mode ultrasonography, patient-reported pain (VAS), and clinical assessment of induration.”
In 50 women after tumescent liposuction, quantitative ultrasound elastography and B-mode measured postoperative stiffness (e.g., 14.8 +/- 3.1 kPa) and fibrotic changes to assess serrapeptase.
The article uses ultrasound (QUS and B-mode) to assess postoperative tissue stiffness/fibrosis in lipedema patients, but does not test ultrasound's ability to diagnose or classify lipedema itself; it studies serrapeptase efficacy, making it
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000003